Disclosed is a process of treating a patient suffering from cancer. The process compriese administering to a patient over a period of up to about 15 days a first component and a second component. The first component consists of a pharmaceutical composition containin as an active ingreadient a compound of formula (I) or a pharmaceutically acceptable salt or ester of said compound. the second ocmponenet consists of a n injection solution containing as an active ingredient paclitaxel. The amount of each componet in the combination is such that the combination is therapeutically effective. The components are administered concomitantly or sequentially ina three week to four week treatment cycle for as long as the tumor remains under control and the patient tolerates the regimen.
申请公布号
WO02064214(A2)
申请公布日期
2002.08.22
申请号
WO2002EP01042
申请日期
2002.02.01
申请人
F. HOFFMANN-LA ROCHE AG
发明人
BREIMER, LARS, HOLGER;DHINGRA, KAPIL;DHINGRA, URVASHI, HOODA;RITLAND, STEVE